menu
    • menu

    Company profile for Eisai Inc

    NEW Drugs in Dev: 68
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and help to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., the company has a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a ...
    At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and help to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., the company has a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eisai IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Metro Blvd, Nutley, NJ 07110
    Telephone
    Telephone
    +1 2016921100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://us.eisai.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eisai/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/eisaius?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eisai Invests $8.8M In Malaria, Tuberculosis, And NTD R&D Project
    Eisai Invests $8.8M In Malaria, Tuberculosis, And NTD R&D Project

    02 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/total-investment-of-approx-usd-8-8-million-in-malaria-tuberculosis-and-ntd-rd-projects-with-partners-including-mahidol-university-barcelona-institute-for-global-health-and-eisai-302675840.html

    PR NEWSWIRE
    02 Feb 2026
    Share Share
    Eisai Seeks EMA Approval For Leqembi IV Maintenance Dosing
    Eisai Seeks EMA Approval For Leqembi IV Maintenance Dosing

    26 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-submits-marketing-authorisation-variation-to-ema-for-intravenous-maintenance-dosing-every-four-weeks-with-leqembi-lecanemab-302670394.html

    PR NEWSWIRE
    26 Jan 2026
    Share Share
    FDA Accepts LEQEMBI IQLIK sBLA as a Subcutaneous
    FDA Accepts LEQEMBI IQLIK sBLA as a Subcutaneous

    25 Jan 2026

    // GLOBENEWSWIRE

    https://www.eisai.com/news/2026/news202605.html

    GLOBENEWSWIRE
    25 Jan 2026
    Share Share
    BMS Snags Top Neuro Researcher From Eisai—Chutes & Ladders
    BMS Snags Top Neuro Researcher From Eisai—Chutes & Ladders

    23 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/chutes-ladders-bms-snags-top-neuro-researcher-eisai

    FIERCE BIOTECH
    23 Jan 2026
    Share Share
    Nuvation Bio, Eisai Sign Taletrectinib Deal in Europe
    Nuvation Bio, Eisai Sign Taletrectinib Deal in Europe

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/nuvation-bio-and-eisai-enter-into-exclusive-licensing-agreement-for-taletrectinib-in-europe-and-addi

    PHARMIWEB
    12 Jan 2026
    Share Share
    Eisai's EA Pharma Starts Phase III Trial For Evenamide
    Eisai's EA Pharma Starts Phase III Trial For Evenamide

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/ea-pharma-a-subsidiary-of-eisai-announces-the-initiation-of-its-phase-iii-clinical-trial-with-even

    PHARMIWEB
    07 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Eisai Inc and get a quotation

    Eisai Inc is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of MOH040 bulk with DMF offered by Eisai Inc

    Find a price of INTERLEUKIN-2 DIPHTHERIA TOXIN FUSION PROTEIN (DAB 389 IL-2) bulk offered by Eisai Inc

    Find a price of Eperisone Hydrochloride bulk offered by Eisai Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search